Israel Cell And Gene Therapy Clinical Trial Services Market (2025-2031) | Trends, Share, Forecast, Size & Revenue, Value, Segmentation, Analysis, Industry, Outlook, Competitive Landscape, Growth, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F

3.3 Israel Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle

3.4 Israel Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces

3.5 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F

3.6 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.7 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F

3.8 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing investment in research and development in the field of cell and gene therapy in Israel

4.2.2 Increasing prevalence of genetic disorders and chronic diseases driving the demand for clinical trials in cell and gene therapy

4.2.3 Favorable regulatory environment and government support for advancing cell and gene therapy research in Israel

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy clinical trials impacting the adoption rate

4.3.2 Limited availability of skilled professionals and specialized infrastructure for conducting clinical trials in Israel

6.1 Israel Cell And Gene Therapy Clinical Trial Services Market, By Service

6.1.1 Overview and Analysis

6.1.2 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F

6.1.3 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F

6.1.4 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F

6.1.5 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F

6.1.6 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F

6.1.7 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F

6.1.8 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Cell And Gene Therapy Clinical Trial Services Market, By Phase

6.2.1 Overview and Analysis

6.2.2 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F

6.2.3 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F

6.2.4 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F

6.2.5 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F

6.3 Israel Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas

6.3.1 Overview and Analysis

6.3.2 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F

6.3.4 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.3.5 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F

6.3.7 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

6.4 Israel Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type

6.4.1 Overview and Analysis

6.4.2 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.4.3 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F

6.4.4 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.4.5 Israel Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F

7.1 Israel Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries

7.2 Israel Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries

8.1 Patient recruitment and retention rates for cell and gene therapy clinical trials in Israel

8.2 Number of partnerships and collaborations between research institutions, biotech companies, and academic centers for advancing cell and gene therapy research

8.3 Rate of successful clinical trial completion and regulatory approvals for cell and gene therapy treatments in Israel

9.1 Israel Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F

9.2 Israel Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F

9.3 Israel Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F

9.4 Israel Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

10.1 Israel Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024

10.2 Israel Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters